Skip to main content
Premium Trial:

Request an Annual Quote

Downloads and Upgrades: Geneious R7, Maverix Biomics, DNAStar, and more


Biomatters has launched Geneious R7, the latest version of its genomic data analysis software.

This version of the tool includes tools to create and share workflows, perform one-step fragment cloning using Gibson assembly, find rare codons, and new plugins for tree building and viewing, alignment and assembly.

Maverix Biomics is offering reduced pricing for its cloud-based RNA-sequencing analysis service to federally funded researchers that will last for the duration of the government shutdown.

The company is charging $99 per sample for RNA-seq analysis including data filtering and quality control, differential gene expression quantification, and visualization capabilities. It will take orders with a minimum of 10 samples and up to 50 million reads per sample

DNAStar said this week that it will offer free use of its software for the duration of government shutdown. Interested researchers are encouraged to contact the company for details.

PerkinElmer has launched a new version of its electronic laboratory notebook dubbed E-Notebook 2014. It includes improvements such as full integration with inventory and registration and protocols for numerous biological applications.

PE has also signed an agreement with Tibco Software to offer the Tibco Spotfire data visualization software platform to clinical, translational, and personalized medicine markets.

The developers of the Structural Classification of Proteins, or SCOP, and ASTRAL databases have released version 1.75C of the combined resources.

This release includes bug fixes and automated classification of many new PDB files released before August 29, 2013.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.